Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are new oral drugs for the therapy of patients with type 2 diabetes mellitus (T2DM). Research in the past decade has shown that drugs of the SGLT2i class, such as empagliflozin, canagliflozin, and dapagliflozin, have pleiotropic effects in preventin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Theranostics
Hoofdauteurs: Liu, Zhenghong, Ma, Xiaoxuan, Ilyas, Iqra, Zheng, Xueying, Luo, Sihui, Little, Peter J., Kamato, Danielle, Sahebkar, Amirhossein, Wu, Weiming, Weng, Jianping, Xu, Suowen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ivyspring International Publisher 2021
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7977463/
https://ncbi.nlm.nih.gov/pubmed/33754074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.54498
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items